B

Biolight Life Sciences Ltd
TASE:BOLT

Watchlist Manager
Biolight Life Sciences Ltd
TASE:BOLT
Watchlist
Price: 368.9 ILS 1.68% Market Closed
Market Cap: ₪33.4m

Operating Margin

-63 200%
Current
Declining
by 49 181%
vs 3-y average of -14 019%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-63 200%
=
Operating Income
₪-13.3m
/
Revenue
₪21k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-63 200%
=
Operating Income
₪-13.3m
/
Revenue
₪21k

Peer Comparison

Country Company Market Cap Operating
Margin
IL
Biolight Life Sciences Ltd
TASE:BOLT
32.5m ILS
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
168.1B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.7B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.3B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 100% of companies in Israel
Percentile
0th
Based on 734 companies
0th percentile
-63 200%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

Biolight Life Sciences Ltd
Glance View

BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.

BOLT Intrinsic Value
2.7 ILS
Overvaluation 99%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-63 200%
=
Operating Income
₪-13.3m
/
Revenue
₪21k
What is Biolight Life Sciences Ltd's current Operating Margin?

The current Operating Margin for Biolight Life Sciences Ltd is -63 200%, which is below its 3-year median of -14 019%.

How has Operating Margin changed over time?

Over the last 3 years, Biolight Life Sciences Ltd’s Operating Margin has decreased from -58 948.6% to -63 200%. During this period, it reached a low of -63 200% on Oct 30, 2025 and a high of -3 663.8% on Sep 30, 2024.

Back to Top